Treatment of melanoma lesions using methylene blue and RL50 light source (2004)

Peer-Reviewed Study · Tardivo JP; Del Giglio A; Paschoal LH; Ito A; Baptista MS · December 2004

Tardivo JP et al., 2004-12: Short report by the São Paulo group describing treatment of human melanoma lesions with methylene blue and a non-coherent RL50 light source; it is the clinical companion to their melanoma programme and the animal work in MTM-19.

Treatment of melanoma lesions using methylene blue and RL50 light source

Tardivo JP et al., 2004-12: Short report by the São Paulo group describing treatment of human melanoma lesions with methylene blue and a non-coherent RL50 light source; it is the clinical companion to their melanoma programme and the animal work in MTM-19. Study type: short communication/letter on clinical melanoma cases (N not stated in the PubMed record). Country: Brazil. Dose: methylene blue injected into lesions, concentration per full text; light: RL50 non-coherent source (fluence per full text). Comparator: none. Funder/conflicts: not stated. Quote is a RECORD FIELD (the article title as indexed in PubMed); PubMed carries no abstract for this item and the Elsevier full text is paywalled, so the full document could not be opened – hence LOW confidence. Recorded so that melanoma is represented among the human photodynamic cases; the verified human melanoma detail in this run is Tardivo's 2005 review (MTM-44 below) and the 2006 Kaposi report (MTM-03). Study type: other.